Royal Bank of Canada
MRKR icon

Royal Bank of Canada’s Marker Therapeutics MRKR Stock Holding History

Royal Bank of Canada’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15
Closed – – 7212
2024
Q2 		$0 Hold
15
– – ﹤0.01% 7358
2024
Q1 		$0 Sell
15
-16
-52% -$70 ﹤0.01% 7376
2023
Q4 		$0 Hold
31
– – ﹤0.01% 7413
2023
Q3 		$0 Hold
31
– – ﹤0.01% 7380
2023
Q2 		$0 Hold
31
– – ﹤0.01% 7508
2023
Q1 		$0 Buy
31
+10
+48% +$24 ﹤0.01% 7323
2022
Q4 		$0 Buy
21
+20
+2,000% +$69 ﹤0.01% 7537
2022
Q3 		$0 Sell
1
-37
-97% -$136 ﹤0.01% 7694
2022
Q2 		$0 Buy
+38
New +$126 ﹤0.01% 7585
2021
Q3 		– Sell
-153
Closed -$4K – 7774
2021
Q2 		$4K Sell
153
-446
-74% -$11.7K ﹤0.01% 7122
2021
Q1 		$13K Buy
599
+293
+96% +$6.7K ﹤0.01% 6678
2020
Q4 		$4K Sell
306
-44
-13% -$683 ﹤0.01% 6734
2020
Q3 		$5K Buy
350
+217
+163% +$3.96K ﹤0.01% 6135
2020
Q2 		$3K Sell
133
-693
-84% -$15.2K ﹤0.01% 6192
2020
Q1 		$16K Buy
826
+741
+872% +$18.9K ﹤0.01% 5635
2019
Q4 		$2K Sell
85
-171
-67% -$6.22K ﹤0.01% 6564
2019
Q3 		$13K Sell
256
-113
-31% -$6.68K ﹤0.01% 5681
2019
Q2 		$29K Buy
369
+319
+638% +$18.9K ﹤0.01% 5532
2019
Q1 		$3K Hold
50
– – ﹤0.01% 6432
2018
Q4 		$3K Buy
50
+49
+4,900% +$3.57K ﹤0.01% 6342
2018
Q3 		$0 Buy
+1
New +$86 ﹤0.01% 6861
2018
Q1 		– Hold
0
– – – 6627
2017
Q4 		– Hold
0
– – – 6750
2017
Q3 		– Hold
0
– – – 6876

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
AR Asset Management West Hollywood, California $546M AUM 24.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
I
INVST Indianapolis, Indiana $886M AUM 21.79% 1-Year Est. Return

Royal Bank of Canada's MRKR Position: Q3 2024 in Review

Royal Bank of Canada sold out of Marker Therapeutics (MRKR) in Q3 2024, closing a stake of 15 shares.

Royal Bank of Canada first reported a position in MRKR in Q3 2018 and held it in 21 quarters. The position peaked at $29K in Q2 2019. 28 funds tracked by Wall St. Rank hold MRKR as of Q3 2024.

  • Royal Bank of Canada reported no remaining Marker Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 15 Marker Therapeutics shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Marker Therapeutics in Q3 2018 and held it in 21 quarters.
  • Royal Bank of Canada's Marker Therapeutics position peaked at $29K in Q2 2019.
  • 28 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.